BSE filing, NSE: GAUDIUMIVF. Summary written from the filing by ALFA Finder's alert engine.
Gaudium IVF And Women Health Ltd: key numbers
- Share price
- ₹99.27
- Market cap
- ₹722.6 Cr
- Revenue (annual)
- ₹104.4 Cr
- Net profit (annual)
- ₹24.46 Cr
- P/E (TTM)
- 31.2×Sector 36.4×
- Promoter holding
- 71.29%+0.00% QoQ
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gaudium IVF And Women Health Ltd
All →Gaudium IVF And Women Health Annual General Meeting
Gaudium IVF conducted its 11th Annual General Meeting on September 28, 2026, via video conferencing, transacting all businesses specified in the AGM notice.
Gaudium IVF And Women Health Capacity Expansion
Gaudium IVF and Women Health Limited commenced operations at its new IVF Centre/Hub in Gurgaon, Haryana, effective September 24, 2026.
- new IVF center
- 1.0 centers
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Limited has intimated the exchange about sending physical letters to shareholders for accessing the Annual Report for FY 2025-26.
Gaudium IVF And Women Health Annual Report
Gaudium IVF and Women Health Limited submitted its Annual Report for the Financial Year 2025-26. The 11th Annual General Meeting is scheduled for September 28, 2026.
Gaudium IVF And Women Health Annual General Meeting
Gaudium IVF and Women Health Limited will hold its 11th AGM on September 28, 2026. The meeting will be conducted via Video Conferencing to consider several resolutions.
Gaudium IVF And Women Health Investor Presentation: Key Takeaways
Gaudium IVF reported Q1 FY27 consolidated revenue of Rs. 1,937.66 Lakhs, up 9.13% YoY, while front-loading expansion costs for new hubs and AI integration.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.